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Insulin resistance and hyperinsulinemia are strong correlates of obesity and type 2 diabetes, but little is known
about their genetic determinants. Using data on nondiabetics from Mexican American families and a multipoint
linkage approach, we scanned the genome and identified a major locus near marker D6S403 for fasting “true”
insulin levels (LOD score 4.1, empirical ), which do not crossreact with insulin precursors. Insulin resis-P ! .0001
tance, as assessed by the homeostasis model using fasting glucose and specific insulin (FSI) values, was also strongly
linked (LOD score 3.5, empirical ) with this region. Two other regions across the genome were found toP ! .0001
be suggestively linked to FSI: a location on chromosome 2q, near marker D2S141, and another location on
chromosome 6q, near marker D6S264. Since several insulin-resistance syndrome (IRS)–related phenotypes were
mapped independently to the regions on chromosome 6q, we conducted bivariate multipoint linkage analyses to
map the correlated IRS phenotypes. These analyses implicated the same chromosomal region near marker D6S403
(6q22-q23) as harboring a major gene with strong pleiotropic effects on obesity and on lipid measures, including
leptin concentrations (e.g., LODeq for traits-specific insulin and leptin was 4.7). A positional candidate gene for
insulin resistance in this chromosomal region is the plasma cell-membrane glycoprotein PC-1 (6q22-q23). The
genetic location on chromosome 6q, near marker D6S264 (6q25.2-q26), was also identified by the bivariate analysis
as exerting significant pleiotropic influences on IRS-related phenotypes (e.g., LODeq for traits-specific insulin and
leptin was 4.1). This chromosomal region harbors positional candidate genes, such as the insulin-like growth factor
2 receptor (IGF2R, 6q26) and acetyl-CoA acetyltransferase 2 (ACAT2, 6q25.3-q26). In sum, we found substantial
evidence for susceptibility loci on chromosome 6q that influence insulin concentrations and other IRS-related
phenotypes in Mexican Americans.
Introduction
The incidences of obesity and type 2 diabetes have been
increasing alarmingly across the globe, especially in the
Western world (Burke et al. 1999; Must et al. 1999),
for most of the 20th century. Hyperinsulinemia and/or
insulin resistance is a strong correlate of obesity and type
2 diabetes in various populations, including Mexican
Americans (Haffner et al. 1990; Groop et al. 1991; Ra-
vussin 1995). Insulin resistance and/or hyperinsulinemia
often clusters with various metabolic abnormalities—
including obesity, dyslipidemia, and hemodynamic
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traits—and this constellation of metabolic disorders has
been referred to as “insulin-resistance syndrome” (IRS)
(Reaven 1988; DeFronzo 1995). The IRS has been
shown to be a predictor of coronary heart disease (CHD)
events as well (Lempiainen et al. 1999). Not only do
Mexican Americans have high rates of type 2 diabetes
and obesity, compared with non-Hispanic whites (Stern
and Haffner 1990), but nondiabetic Mexican Americans
have been found to have higher insulin levels and to be
more insulin-resistant than nondiabetic non-Hispanic
whites (Haffner et al. 1990). Also, among Mexican
Americans, individuals who later developed multiple
metabolic abnormalities were found to have higher in-
sulin levels at baseline than those who developed only
a single abnormality (Haffner 1999).
Although several rare genetic syndromes (e.g., lepre-
chaunism and type A IRS) have been found to have
severe insulin resistance (Flier 1992; Kahn et al. 1996),
knowledge about genetic regions that influence insulin
concentrations and the various constituents of IRS in
1150 Am. J. Hum. Genet. 68:1149–1164, 2001
the general population is limited. In this study, therefore,
we conducted a genomewide scan and employed a mul-
tipoint variance components approach to identify sus-
ceptibility loci influencing fasting specific insulin (FSI)
concentrations in nondiabetic Mexican Americans dis-
tributed across 27 extended families. In contrast to lev-
els of conventional fasting immunoreactive insulin or
nonspecific insulin (FNI), FSI levels do not crossreact
with insulin precursors (Hales 1995; Haffner et al.
1997). Because the major chromosomal regions of in-
terest in this study provided strong evidence for linkage
not only to measures of insulin concentration and in-
sulin resistance, as calculated by the homeostatic model
assessment measure of insulin resistance (i.e., HOMA
%S), (Matthews et al. 1985; Levy et al. 1998) but also
to other IRS-related phenotypes, including body-mass
index (BMI), leptin (LEPT), sum of skin folds (SS), and
ln triglycerides (ln TG), a bivariate multipoint linkage
technique was used to determine whether mapping of
these correlated traits to the same chromosomal regions
was due to pleiotropy.
Material and Methods
San Antonio Family Diabetes Study
Phenotypic data.—The San Antonio Family Diabetes
Study (SAFADS) includes 32 low-income Mexican
American extended families, which were ascertained on
type 2 diabetic probands, containing 579 (140 diabetics)
examined individuals, aged 18–98 years. Metabolic, an-
thropometric, demographic, and medical-history infor-
mation was obtained on all the examined individuals.
A subset of 440 individuals (116 diabetics) from the 27
largest pedigrees were selected for genotyping. For the
present analyses, we used phenotypic information from
nondiabetic subjects only from these families (∼310 in-
dividuals depending on availability of data). All proce-
dures were approved by the institutional review board
of the University of Texas Health Science Center at San
Antonio, and all subjects gave informed consent.
Blood samples were obtained after a 12-h fast for
assessment of various metabolic traits. Fasting plasma
glucose (FG) concentrations were measured using an Ab-
bott Bichromatic Analyzer (Abbott). Serum immuno-
reactive insulin or FNI levels were measured using a
radioimmunoassay (Diagnostic Products). Triglyceride
(TG) levels were measured by enzymatic procedures as
described elsewhere (Stern et al. 1984). Fasting specific
insulin (FSI) concentrations were measured using a mon-
oclonal antibody-based two-site immunoradiometric as-
say (kindly performed by C. N. Hales; see Sobey et al.
[1989]). Unlike conventional insulin immunoassays, in-
sulin measured by this assay does not crossreact with
insulin precursors. LEPT levels were measured by a com-
mercial radioimmunoassay (Linco Research; see Ma et
al. [1996]).
Using FG and FSI concentrations, estimates of pan-
creatic b-cell function (HOMA %b) and insulin sensi-
tivity (HOMA %S, an inverse measure of insulin resis-
tance) were derived by means of the homeostasis model
assessment (HOMA) method (Matthews et al. 1985;
Levy et al. 1998; Hermans et al. 1999a, 1999b). This
method is based on a structural computer model of a
glucose/insulin feedback system that incorporates math-
ematical descriptions of the function and interactions of
different organs involved in FG control on the basis of
empirical data. The model allows the use of either im-
munoreactive (or nonspecific) insulin or specific (or true)
insulin assays since proinsulin is included in the model.
The estimates of HOMA %b and HOMA %S are de-
rived from FG and FSI concentrations of an individual
and are expressed relative to values in a young, lean
reference population. The measures of HOMA %S and
HOMA b% have been shown to perform well in com-
parison with other direct measures of insulin sensitivity
and b-cell function, respectively (Levy et al. 1998; Her-
mans et al. 1999a, 1999b), particularly in nondiabetics.
However, we acknowledge that we do not have data on
direct measures of either insulin secretion or insulin re-
sistance. For the present study, log-transformed HOMA
%b (ln HOMA %b) and HOMA %S (ln HOMA %S)
were used.
Blood samples were obtained again 2 h after a stan-
dardized oral glucose load (World Health Organization
Expert Committee 1985) for plasma glucose. Diabetes
was diagnosed according to the World Health Organi-
zation (WHO) plasma glucose criteria (World Health
Organization Expert Committee 1985). Individuals who
did not meet the WHO criteria but reported a history
of diabetes and that they were under treatment with
insulin or oral antidiabetic agents were also considered
to have diabetes. Individuals with diabetes were ex-
cluded from the present analyses. The anthropometric
data were collected using standardized anthropometric
protocols (Haffner et al. 1987). BMI was calculated as
weight (in kg) divided by height (in m) squared. The sum
of eight skin-fold measures (SS) was used as a measure
of overall subcutaneous adiposity (Duggirala et al.
1996). Trait-specific distinct outliers were excluded from
the analyses (e.g., TG values 1800 mg/dl). For the pre-
sent study, log-transformed triglyceride (ln TG) and FNI
(ln FNI) values were used, since each of their untrans-
formed values exhibited high nonnormality.
Genotypic data.—An ∼10–15-cM map, which has
been described in detail elsewhere (Duggirala et al.
1999b, 2000), was utilized for the multipoint linkage
analysis. In brief, genotypes were collected primarily by
polymerase chain reaction (PCR) assays with radio-
labeled oligonucleotide primers. However, data for some
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of the markers were collected by use of fluorescence-
labeled primers purchased from Research Genetics. The
latter were PCR amplified and were loaded onto an Ap-
plied Biosystems Model 373 sequencer, and the data
were analyzed with Applied Biosystems Genotyper soft-
ware. The genotypic data were analyzed for discrep-
ancies (i.e., violations of Mendelian inheritance), by
means of the program INFER (Dyke 1996). Such dis-
crepancies were checked in the laboratory for mistyping,
and markers for discrepant individuals were either cor-
rected or blanked out prior to analysis. A total of 419
markers have been typed, and all markers were used for
two-point linkage analysis. As described elsewhere (Dug-
girala et al. 2000), since our multipoint linkage approach
yields optimum results when similar numbers of indi-
viduals are genotyped at all loci, markers with !80% of
the sample genotyped were not used for multipoint anal-
ysis, unless their absence would result in a map gap of
20 cM. The multipoint analyses were thus conducted
using genotypic information from 301 markers. The sex-
averaged maps were constructed using the SAFADS
marker data and the program CRI-MAP (Green et al.
1990), supplemented by the map information in the Co-
operative Human Linkage Center (Murray et al. 1994),
the Genome Database (Fasman et al. 1996), the Genetic
Location Database (Collins et al. 1996), and the Marsh-
field Medical Research Foundation (Broman et al. 1998).
Multipoint Linkage Analyses
Univariate multipoint linkage analysis.—A variance-
components approach was used to test for linkage of a
genetic location with a given phenotype (i.e., univariate)
using maximum-likelihood methods (Amos 1994; Al-
masy and Blangero 1998). This method utilizes infor-
mation from all possible pedigree relationships simul-
taneously, to examine the genetic architecture of a
quantitative trait, and is based on specifying the expected
genetic covariances between relatives as a function of
their identity by descent (IBD) relationships at a marker
locus (which is hypothesized to be linked to a locus
influencing the quantitative trait—i.e., a “quantitative-
trait locus” [QTL]). It allows for locus-specific effects
( p heritability attributed to the QTL), residual ad-2hq
ditive genetic effects ( p heritability attributed to the2h
residual genetic effects), covariate effects (e.g., age and
sex), and individual-specific random environmental fac-
tors: .2 2 2e p 1 (h  h )q
In the present study, in addition to the variance com-
ponents, mean, and standard deviation of the phenotype
and covariate effects (i.e., sex and age terms) were es-
timated, simultaneously, using maximum-likelihood
techniques. Likelihood-ratio tests were used to test var-
ious hypotheses. The hypothesis of no linkage (i.e., ad-
ditive genetic variance caused by the QTL being 0) is
tested by comparing the likelihood of this restricted
model with that of a model in which the additive genetic
variance due to the QTL is estimated. Twice the differ-
ence in ln likelihoods of these two models yields a test
statistic (L) that is asymptotically distributed as a 1/2:
1/2 mixture of a x21 and a point mass at zero (Self and
Liang 1987). LOD scores are obtained by converting the
ln likelihood values into values of log to the base 10.
After obtaining locus-specific IBD information for pairs
of relatives using the program SOLAR (Almasy and
Blangero 1998), the multipoint mapping technique, as
implemented in the program SOLAR, was used to carry
out multipoint linkage analyses. To verify the findings
from the multipoint linkage analyses, we conducted sim-
ulation analyses to determine the trait-specific empirical
P values using the following procedure. A fully infor-
mative marker was simulated, which was not linked to
a given phenotype. For this marker, IBD information was
calculated, and then linkage analysis was performed. For
a given phenotype, we generated the empirical P values
on the basis of LOD-score distribution obtained from
the 10,000 replicates.
Bivariate multipoint linkage analysis.—In contrast to
the above phenotype-specific multipoint linkage analy-
sis, a bivariate (i.e., two-phenotype) multipoint linkage
was used to exploit the additional information embed-
ded in the correlation pattern between two quantitative
traits. Given the theoretical background for exploitation
of the genetic basis of multivariate quantitative pheno-
types (Lange and Boehnke 1983; Boehnke et al. 1986),
the variance-components approach has been extended
to the bivariate situation to test whether covariances
between a given set of phenotypes are due to pleiotropic
effects of a major gene in the chromosomal region of
interest (Almasy et al. 1997; Williams et al. 1999a,
1999b).
After the initial findings of correlated traits that map
to the same chromosomal location, the bivariate linkage
technique was used to estimate the correlation caused
by a major gene ( ), the correlation caused by residualrq
additive genetic effects ( ), and the correlation causedrg
by random environmental effects ( ). In each of there
bivariate analyses, in addition to these three correlation
estimates, two trait-specific means, variance components
relating to major-gene effects, residual additive genetic
effects, random environmental effects, and covariate ef-
fects (i.e., sex and age terms) were estimated simulta-
neously using maximum-likelihood techniques. The hy-
pothesis tests were performed by likelihood-ratio tests.
The hypothesis of no linkage for either trait (i.e., additive
genetic variance caused by the QTL is 0 for both traits)
was tested by comparison of the likelihood of this re-
stricted model with that of a model in which the additive
genetic variance caused by the QTL for both traits was
estimated. The bivariate LOD score obtained with this
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Table 1
Characteristics of Nondiabetic SAFADS Subjects Distributed by Sex
across 27 Families
Variable and Sexa N Mean  SD or %
Sex:
M 137 42%
F 187 58%
Age (years):
M 137 39.5  16.9
F 187 37.5  14.2
FG (mg/dl):
M 136 91.0  11.7
F 187 87.1  10.3
Fasting specific insulin (pmol/L):
M 124 120.4  85.1
F 169 133.4  87.0
ln HOMA %S:
M 121 3.8  0.6
F 169 3.8  0.7
ln HOMA %b:
M 124 5.0  0.5
F 169 5.2  0.4
ln Fasting nonspecific insulin:
M 130 2.4  0.7
F 180 2.4  0.7
ln Triglycerides:
M 132 5.1  0.6
F 179 4.8  0.5
Leptin (ng/ml):
M 121 10.7  7.8
F 171 30.3  18.1
BMI (kg/m2):
M 134 29.4  5.8
F 183 29.4  7.1
Sum of skin folds (mm):
M 135 145.3  47.8
F 184 195.1  52.6
a M p male; F p female.
method involves 2 df. Hence, it is not directly compa-
rable to the LOD score obtained from the univariate
linkage analysis. Twice the difference in ln likelihoods
of these two models yields a L that is asymptotically
distributed as a 1/4:1/2:1/4 mixture of x22, x
2
1, and x
2
0
(Self and Liang 1987). The bivariate LOD score with 2
df can be adjusted to 1 df, denoted as LODeq score, by
requiring it to provide the same P value as is provided
by the true bivariate LOD score (Almasy et al. 1997;
Williams et al. 1999a). Thus, the LODeq score can be
considered equivalent to the classical univariate LOD
score.
Likelihood-ratio tests were used to test the hypotheses
of complete pleiotropy (i.e., the same major gene in the
chromosomal region of interest affects both traits) and
coincident linkage (i.e., no shared major gene effects in
the chromosomal region of interest on the two traits).
The test of complete pleiotropy is carried out by com-
paring the likelihood of a restricted model in which rq
is constrained to 1 (or 1) to that of a model in which
is estimated. It should be noted that a positive valuerq
of 1 for is chosen for trait pairs involving FSI andrq
other phenotypes because all of the overall polygenic
correlations between these trait pairs were found to be
positive. In the case of trait pairs relating to ln HOMA
%S (i.e., an inverse measure of insulin resistance) and
other traits, however, a negative value of 1 for isrq
chosen since all of the overall polygenic correlations be-
tween the examined trait pairs involving ln HOMA %S
were found to be negative. Since the hypothesis of rq
equals 1 (or 1) involves a boundary condition, twice
the difference in likelihoods of these two models yields
a L that is asymptotically distributed as a 1/2:1/2 mix-
ture of a x21 and a point mass at 0 (Self and Liang 1987).
In the case of test of coincident linkage (i.e., ),r p 0q
twice the difference in likelihoods of the two competing
models yields a L that is asymptotically distributed as a
x2 with 1 df. The bivariate linkage analyses were carried
out using a modified version of the program SOLAR.
For a given phenotype pair, we used the simulation strat-
egy already described to generate the empirical P values
based on the bivariate LOD score distribution obtained
from the 10,000 replicates.
Results
The characteristics of the nondiabetic subjects used for
the present study are reported in table 1. All genetic
analyses included sex and age terms as covariates. Prior
to conducting the linkage analyses, we determined her-
itabilities for all the phenotypes used in this study. The
overall additive genetic heritabilities ranged from 26%
(ln TG) to 65% (BMI). Following the findings that all
of these phenotypes were significantly heritable, we ex-
amined the nature of genetic correlations between the
trait pairs analyzed in this study. The additive genetic
correlations between FSI and other phenotypes were
positive, as expected, and ranged from .47 (FSI–ln TG)
to .80 (FSI–SS and FSI–LEPT). Since HOMA %S is an
inverse measure of insulin resistance, the additive genetic
correlations between ln HOMA %S and others traits
were negative, ranging from .46 (ln HOMA %S–ln
TG) to .81 (ln HOMA %S–LEPT). These correlations
suggest strong common genetic influences on the ex-
amined trait pairs, especially the ones involving FSI or
ln HOMA %S and obesity measures.
The results of our multipoint genome scan for FSI
susceptibility loci are reported in figure 1. The highest
LOD score that we observed was 4.1 (empirical P value
!.0001), corresponding to a major susceptibility locus
for FSI on chromosome 6q at 150 cM from p-ter. This
genetic location is 2 cM telomeric to the marker
D6S403. The multipoint LOD score profile obtained for
FSI is shown in figure 2. As can be seen from this figure,
the chromosomal region containing the putative locus
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Figure 1 Summary of the multipoint linkage analyses of FSI:
peak multipoint LOD score by chromosome.
for FSI levels is rather broad, and the 1-LOD support
interval surrounding the peak extends from 135 to 161
cM from p-ter. After accounting for the covariate ef-
fects, this major susceptibility locus (h2q) explains
44%8% ( ) of the phenotypic varia-6Pp 7.5# 10
tion in FSI levels. In addition to the major genetic lo-
cation near marker D6S403, six other regions on five
separate chromosomes were found to exhibit some ev-
idence for linkage, with LOD scores 11.5 (fig. 1). Spe-
cifically two genetic regions, one on chromosome 2q
near marker D2S141 (LOD score 2.7; empirical P value
.0006) and another on chromosome 6q near marker
D6S264 (LOD score 2.2; empirical P value .0018), are
suggestively linked to FSI concentrations. For the re-
maining chromosomal regions, the LOD scores ranged
from 1.6 (empirical P value .0072) to 1.9 (empirical P
value .0038) as follows: a genetic location between
markers D11S1984-D11S988 (LOD score 1.6) and an-
other near marker D11S934 (LOD score 1.8) on chro-
mosome 11, a genetic location near marker D18S535
(LOD score 1.7) on chromosome 18, and a genetic lo-
cation near marker D20S119 (LOD score 1.9) on chro-
mosome 20.
The major chromosomal region of interest for FSI,
the genetic location near D6S403, showed varying de-
grees of evidence for linkage to several other IRS-related
phenotypes including nonspecific insulin (ln FNI) and
other IRS-related traits (BMI, SS, LEPT, and ln TG)
(table 2). Similar patterns of linkage profile for these
phenotypes could also be seen at the genetic region near
marker D6S264. Since hyperinsulinemia could result
from abnormalities of either insulin action or secretion,
we derived measures of insulin sensitivity (HOMA %S)
and b-cell function (HOMA %b) to evaluate the extent
of their linkage to the two regions on chromosome 6q.
As shown in figure 2, both regions of interest on chro-
mosome 6q exhibit strong evidence for linkage of ln
HOMA %S with LOD scores of 3.5 (empirical P value
!.0001) and 2.7 (empirical P value .0002), respectively
(table 2). By contrast, ln HOMA %b, reflecting insulin
secretion, appears to be only weakly linked to these
regions (table 2 and fig. 2). On the basis of the trait-
specific linkage profiles, the two peaks on chromosome
6q, which are 150 cM apart, appear to represent two
distinct genetic locations influencing FSI and other IRS-
related phenotypes (fig. 2 and table 2).
Following the above findings of linkage of multiple
correlated phenotypes to the same chromosomal region
involving the ordered markers D6S1009-D6S403-
D6S1003, we extended our analytical approach to the
bivariate situation to exploit the additional information
underlying the patterns of covariation between pairs of
quantitative phenotypes. Table 3 presents the results
from multipoint bivariate linkage analyses of various
pairs of IRS-related traits. As shown in this table for
the region near marker D6S403, for the trait pairs in-
volving FSI and other traits, the bivariate LOD scores
with 2 df range from 3.9 (FSI-BMI) to 5.4 (FSI-LEPT).
The L obtained for each of these bivariate linkage tests
is distributed as a mixture of x2 distributions, as shown
in table 3. Thus, the P values range from 54.8# 10
(FSI-BMI) to (FSI-LEPT). Likewise, the61.5# 10
LODeq score, which is the equivalent 1-df LOD score
corresponding to the stated bivariate LOD score with
2 df, ranges from 3.3 (FSI-BMI) to 4.7 (FSI-LEPT). All
of the LODeq scores for the marker D6S403 region are
13.0, adding further significance to this putative locus
in affecting IRS-related phenotypes. The bivariate link-
age profiles of the measure of insulin resistance (ln
HOMA %S) and other IRS-related phenotypes are sim-
ilar to the findings from the bivariate analyses of FSI
and other IRS traits (figs. 3 and 4). Evidence for bivar-
iate linkage is stronger for FSI and other traits, com-
pared with the ln HOMA %S and other traits (table 3).
For example, the LODeq scores ranged from 2.8 (ln
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Table 2
Linkage of Various IRS-Related Phenotypes to the Regions of
Interest on Chromosome 6q with Variable Degrees of Evidence
PHENOTYPE
REGION COVERED BY
MARKERS D6S1009,
D6S403, AND
D6S1003
REGION
CONTAINING
MARKER
D6S264
cMa LOD cMa LOD
FSI 150 4.1 209 2.2
LEPT 139 2.2 210 2.8
BMI 138 1.5 207 .7
SS 144 1.6 210 1.6
ln TG 156 .8 207 1.3
ln FNI 142 1.9 206 1.1
ln HOMA %S 149 3.5 210 2.7
ln HOMA %b 141 1.4 210 1.7
a Distance from the p-ter.
Figure 2 Plot of LOD scores obtained for measures of insulin (FSI), HOMA %S, and HOMA %b, against map positions on
chromosome 6.
HOMA %S-BMI) to 4.1 (ln HOMA %S-LEPT). For
the trait pairs relating to FSI and other traits, the em-
pirical P values range from .0006 (FSI-BMI) to !.0001
(FSI-ln TG). The empirical P values range from .0004
(ln HOMA %S-ln TG) to .0002 (ln HOMA %S-BMI)
for trait pairs involving ln HOMA %S and other
phenotypes.
Similar patterns of bivariate linkage involving the
same trait pairs could also be seen at the D6S264 marker
region. For this genetic region, the bivariate LOD scores
range from 2.4 (FSI-BMI) to 4.6 (FSI-LEPT), and the
corresponding P values range from (FSI-31.4# 10
BMI) to (FSI-LEPT) (table 3). One of the67.8# 10
four corresponding LODeq scores, involving the trait
pair FSI-LEPT, is well above 3.0. Again, the bivariate
linkage profiles of ln HOMA %S versus other IRS-
related phenotypes are similar to those obtained from
the trait-pair analyses involving FSI and other traits
(figs. 3 and 4). However, at the D6S264 marker region,
evidence for bivariate linkage is slightly stronger for ln
HOMA %S and other traits compared to the FSI and
other traits (table 3). The empirical P values range from
.0039 (FSI-BMI) to .0002 (FSI-ln TG) for trait pairs
involving FSI and other phenotypes. For the trait pairs
relating to ln HOMA %S and other traits, the empirical
P values range from .0005 (ln HOMA %S-BMI) to
.0003 (ln HOMA %S-LEPT). Thus, both univariate and
bivariate linkage analyses implicate the genetic locations
near markers D6S403 and D6S264 as significant regions
of colocalization of the correlated IRS phenotypes. As
can be seen from figures 3 and 4, the bivariate analyses
yielded peaks much sharper than those obtained from
the univariate analyses (fig. 2).
Our bivariate linkage technique quantifies the extent
to which the chromosomal region containing the major
gene affects the correlation between a given pair of
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Table 3
Multipoint Bivariate Linkage Analyses of Selected Pairs of IRS-Related
Phenotypes versus the Marker Regions of Interest on Chromosome 6q
Region and Phenotype Pair cMa
Bivariate
LOD Lb Pc LOD eq
d
Marker D6S403 region:
FSI-BMI 150 3.9 17.74 4.8# 105 3.3
FSI-SS 150 4.7 21.55 6.8# 106 4.1
FSI-LEPT 149 5.4 24.74 1.5# 106 4.7
FSI-ln TG 150 4.3 19.64 1.8# 105 3.7
ln HOMA %S-BMI 150 3.3 15.17 1.8# 104 2.8
ln HOMA %S-SS 150 4.2 19.13 2.4# 105 3.6
ln HOMA %S-LEPT 149 4.7 21.74 6.3# 106 4.1
ln HOMA %S-ln TG 151 3.5 16.00 1.2# 104 2.9
Marker D6S264 region:
FSI-BMI 209 2.4 11.12 1.4# 103 1.9
FSI-SS 209 3.4 15.77 1.3# 104 2.9
FSI-LEPT 208 4.6 21.33 7.8# 106 4.1
FSI-ln TG 207 3.3 15.11 1.8# 104 2.8
ln HOMA %S-BMI 209 2.6 12.08 8.5# 104 2.1
ln HOMA %S-SS 209 3.7 16.89 7.4# 105 3.1
ln HOMA %S-LEPT 208 4.8 22.02 5.8# 106 4.2
ln HOMA %S-ln TG 209 3.4 15.61 1.4# 104 2.9
a Distance from p-ter
b Likelihood-ratio statistic L.
c Asymptotic P value, under the assumption that L is distributed as a ¼x22:½x
2
1:
¼x20 mixture.
d LODeq is the equivalent 1-df LOD score corresponding to the reported bivariate
LOD score with 2 df.
traits. As shown in table 4, the correlations between
trait pairs FSI and other traits caused by the major-gene
effects at the D6S403 region range from .8, for trait
pair FSI-ln TG, to 1, for other trait pairs. In the case
of ln HOMA %S and other trait pairs, the correlations
range from .6, for trait pair FSI-ln TG, to 1, for
other trait pairs (table 4). None of the trait-pair models
of complete pleiotropy (i.e., locus-specific correlation
between a given pair of traits not significantly different
from 1 or 1) could be rejected (table 4), suggesting
significant evidence for pleiotropic effects of the genetic
location near marker D6S403 on all of the IRS-related
trait pairs examined in this study. By contrast, all of the
tests of coincident linkage were strongly rejected. For
the region near marker D6S264, complete pleiotropy
was rejected only for the trait pairs involving ln TG.
For the other trait pairs, coincident linkage was strongly
rejected in favor of complete pleiotropy (table 4).
Discussion
Hyperinsulinemia and/or insulin resistance is a strong
correlate of complex disease conditions, such as obesity
and type 2 diabetes, and may play a role in the patho-
genesis of CHD as well (DeFronzo 1995; Haffner 1999;
Lempiainen et al. 1999). In relation to direct insulin-
resistance measures, such as the euglycemic clamp and
the intravenous glucose-tolerance test, fasting insulin
concentration, a simple noninvasive measure, has been
considered a surrogate measure of insulin resistance in
nondiabetic subjects (Haffner et al. 1997). It is well es-
tablished that insulin levels are under substantial genetic
influences (Stern and Mitchell 1999) and that insulin
levels and other IRS-related phenotypes (e.g., obesity)
are influenced by a common set of genes (i.e., pleiotropy)
(Mitchell et al. 1996). However, knowledge about spe-
cific common genetic determinants of insulin levels or
insulin resistance and their correlates, such as obesity
and dyslipidemia, is extremely limited.
In this study, using a genomewide scan, we found
significant evidence (LOD score 4.1) for a major locus
influencing FSI concentrations on chromosome 6q near
marker D6S403. The evidence for linkage of FSI to this
region is significant at the level of a genomewide scan
according to the criteria proposed by Lander and Krug-
lyak (1995). Furthermore, this genetic region is strongly
linked with HOMA %S, suggesting that the genetic lo-
cation near marker D6S403 is a major determinant of
variation in insulin resistance. Our simulation analyses
add further strength to these findings. By contrast, this
region appears to be weakly linked to HOMA %b, sug-
gesting that the underlying susceptibility gene account-
ing for the linkage primarily influences insulin resis-
tance, rather than insulin secretion. We acknowledge,
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Figure 3 Bivariate linkage profiles of various trait pairs, including FSI and other IRS-related phenotypes on chromosome 6
however, that since we lack direct measures of insulin
resistance and insulin secretion, these interpretations
should be considered tentative. The failure of FNI levels
to provide evidence for linkage as strong as the FSI
concentrations in our study could be due to the fact
that, unlike FNI, FSI denotes “true” insulin concentra-
tion by not crossreacting with insulin precursors. Given
that a high proinsulin:insulin ratio can be considered
indicative of a defect in proinsulin processing or insulin
secretion, our failure to find evidence for linkage of this
ratio to the region near marker D6S403 further
strengthens the argument that the linkage near this
marker is primarily related to insulin resistance.
We subsequently showed, using a bivariate linkage
technique, that the same major gene in the chromosomal
region of interest also had significant shared effects on
other IRS-related phenotypes (e.g., obesity and triglyc-
erides). The bivariate linkage approach has been shown
to substantially improve power to detect susceptibility
loci that have pleiotropic effects on correlated traits and
can help to localize such genes more precisely (Amos
and Liang 1993; Almasy et al. 1997; Allison et al. 1998;
Williams et al. 1999a). All of the bivariate analyses im-
plicate the region near marker D6S403 (6q22-q23) as
harboring the putative susceptibility locus, which ap-
pears to simultaneously affect measures of insulin con-
centration and insulin resistance, as well as other IRS-
related traits, including various measures of obesity/
adiposity and triglyceride levels. Since the traits
examined in this study are genetically correlated, no
attempt has been made to correct for multiple testing.
To date, a number of studies have conducted linkage
analyses to find chromosomal regions harboring type 2
diabetes and metabolic syndrome related susceptibility
loci across the genome. Elsewhere, we reported, on the
basis of sibship analyses, some evidence for linkage of
glucose concentrations to different locations on chro-
mosome 6, including the regions near markers D6S292
and D6S290 (Stern et al. 1996). Given that the marker
D6S292 is on the same cytogenetic band (i.e., 6q22-
q23) as marker D6S403 (fig. 2), Ghosh et al. (2000)
found strong evidence for a locus near marker D6S292
influencing the lowest FG concentrations in a subset of
Finnish families. In another analysis, involving non-
diabetic individuals in the Finnish families, Watanabe
et al. (2000) reported several different locations near
the D6S292 marker region that were linked to pheno-
types such as fasting insulin, 2-h insulin, and measures
of both insulin resistance and insulin secretion.
In a genomewide search for genes influencing systolic
blood pressure, strong evidence for linkage was found
between a location near markers D6S1009 and
D6S1003 and systolic blood pressure (Krushkal et al.
1999). As can be seen from figure 2, these markers flank
D6S403. In Mexican Americans, some evidence for link-
age of cholesterol concentrations in the LDL-3 size frac-
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tion to a location near marker D6S1003 has been
reported (Rainwater et al. 1999). As part of their ge-
nomewide scan for loci linked to obesity measures in a
collection of French families, Hager et al. (1998) re-
ported some evidence for linkage of leptin concentra-
tions to a location, telomeric to marker D6S292, that
corresponds well to our region of interest. This region,
however, in another study involving the Mexican pop-
ulation (Comuzzie et al. 1997), was not implicated as
influencing leptin concentrations. Although we failed to
find evidence for linkage of diabetes to the region near
marker D6S403 in our previous study (Duggirala et al.
1999b), it is worth noting that this region (i.e., markers
D6S1009 and D6S1003) has been reported to be linked
to age-adjusted diabetes in Pima Indians (Hanson et al.
1998a). Also, the marker region D6S1009 has been re-
ported to be linked to diabetes in Japanese subjects (Iwa-
saki et al. 1999). Ghosh et al. (2000) reported evidence
for a diabetes-susceptibility gene, influencing age at di-
agnosis and located on chromosome 6q, that is cen-
tromeric to the region of interest in this study.
Since a chromosomal region implicated by a linkage
analysis may contain a large number of known or un-
known genes, an initial step for genetic epidemiological
investigations would be to identify and examine poten-
tial positional candidate genes in the chromosomal
regions of interest. Such a positional candidate gene for
insulin resistance in our chromosomal region of interest
(i.e., D6S403 region) is the plasma cell membrane gly-
coprotein PC-1 gene (Maddux et al. 1995), which has
been localized to chromosome 6q22-q23 (Buckley et al.
1990). The PC-1 gene, when overexpressed, has been
shown to be an inhibitor of insulin receptor tyrosine
kinase activity, and its levels are elevated in muscle, fat,
and fibroblasts of subjects with insulin resistance (Gold-
fine et al. 1998; Pizzuti et al. 1999). There is evidence
that the PC-1 could inhibit insulin receptor signaling
by interacting with the insulin receptor a-subunit (Mad-
dux and Goldfine 2000). Recently, a polymorphism
(K121Q) in exon 4 of the PC-1 gene has been shown
to be strongly associated with insulin resistance, using
data from a sample of white subjects from Sicily (Pizzuti
et al. 1999). We acknowledge, however, that as yet we
have no direct evidence that functional variants in the
PC-1 gene account for our linkage signal. Another po-
tential candidate gene in our chromosomal region of
interest relates to transient neonatal diabetes mellitus
(TNDM), which is a rare, developmental disorder of
insulin production that regresses in postnatal life (Cave´
et al. 2000). Although TNDM patients generally recover
before 1 year of age, some patients may tend to develop
type 2 diabetes later in life (Gardner et al. 1999; Temple
et al. 2000). The gene for TNDM has been originally
localized to the chromosomal band 6q22-q23 (Temple
et al. 1996). Recently, however, it has been proposed
that the chromosomal bands 6q24.1-q24.3 contain an
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Table 4
Evidence for Pleiotropic Influences of Specific Genetic Regions of
Chromosome 6q on IRS-Related Phenotypes
PHENOTYPE PAIR rq
a
COMPLETE
PLEIOTROPY
COINCIDENT
LINKAGE
Lb pc Lb pd
Marker D6S403 region:
FSI-BMI 1 .00 .5000 13.74 .0002
FSI-SS 1 .00 .4955 19.65 !.0001
FSI- LEPT 1 .00 .4990 17.22 !.0001
FSI-ln TG .8 .23 .3151 6.39 .0115
ln HOMA %S-BMI 1 .00 .4877 13.25 .0003
ln HOMA %S-SS 1 .00 .4972 18.94 !.0001
ln HOMA %S-LEPT 1 .00 .4971 16.47 !.0001
ln HOMA %S-ln TG .6 .84 .1790 4.15 .0416
Marker D6S264 region:
FSI-BMI .9 .93 .1680 7.60 .0059
FSI-SS 1 .00 .4901 15.25 !.0001
FSI-LEPT .9 .09 .3844 16.77 !.0001
FSI-ln TG .5 2.77 .0479 3.44 .0637
ln HOMA %S-BMI .9 .76 .1917 7.91 .0049
ln HOMA %S-SS 1 .00 .4942 15.26 !.0001
ln HOMA %S-LEPT .9 .61 .2172 16.73 !.0001
ln HOMA %S-ln TG .4 2.88 .0450 3.44 .0636
a rq is correlation due to QTL effects.
b Likelihood-ratio statistic L.
c Likelihood for a model in which rq is estimated, compared with
that of another model in which rq is constrained to 1 (or 1) (i.e.,
complete pleiotropy). L is distributed as a ½x21:½x
2
0 mixture.
d Likelihood of a model in which rq is estimated, compared with
another model in which rq is constrained to 0 (i.e., coincident linkage).
L is distributed as a x2 with df 1.
imprinted gene for TNDM (Gardner et al. 1999; Cave´
et al. 2000).
One of the chromosomal regions that appears to be
suggestively linked to FSI (LOD score 2.2) is also on
chromosome 6q, but near marker D6S264 (6q25.2-
q26). However, our bivariate linkage analyses identified
the same region as having significant common effects
on various IRS-related phenotypes. On the basis of the
map used for this study, this genetic region is ∼58 cM
telomeric to D6S403. It is possible that the observed
two peaks on chromosome 6q may be related to the
same chromosomal region. However, the LOD profile
patterns revealed by both univariate and bivariate link-
age analyses are more suggestive of two distinct loci on
chromosome 6q. In Mexican Americans, evidence was
found for linkage of cholesterol concentrations in LDL-
3 size fraction to a genetic location very close to the
marker D6S1277 (Rainwater et al. 1999), which is ∼8
cM centromeric to marker D6S264 on our map. Using
the same Mexican American family data, Mitchell et al.
(1999) reported some evidence for linkage of BMI to a
location near marker D6S1008, which is ∼2 cM cen-
tromeric to marker D6S1277. Recently, syndromal obe-
sity has been shown to be due to paternal duplication
of chromosome 6q involving the chromosomal bands
6q24-q27 (Smith et al. 1999). It is worthwhile to note
that the human homolog of Obq4, a mouse obesity
QTL, could map to the chromosome 6q25-q27 region
(Taylor and Philips 1997). A region near marker
D6S1035, which is not far from D6S264, has been
shown to provide some evidence for linkage with dia-
betes in Pima Indians (Hanson et al. 1998b) and with
the FG concentrations in Mexican Americans (Stern et
al. 1996). The marker D6S264 region has also been
shown to contain a susceptibility locus for IDDM8 (Luo
et al. 1995). This chromosomal region also harbors sev-
eral positional candidate genes for IRS or obesity, such
as the insulin-like growth factor 2 receptor (IGF2R) in
the cytogenetic location 6q26 (MIM 147280), and the
acetyl-CoA acetyltransferase 2 (ACAT2) in the cyto-
genetic location 6q25.3-q26 (MIM 100678). It is also
worth mentioning that the mu 1 opioid receptor gene
(OPRM1; MIM 600018), a candidate gene for obesity,
lies in the cytogenetic position 6q24-q25, between the
peaks of interest in this study.
The second genetic location exhibiting suggestive
linkage to FSI (LOD score 2.7) is on chromosome 2
near marker D2S141 (2q23-24). It has been shown that
the genetic marker D2S141 is physically linked to the
pancreatic b-cell mitochondrial glycerol-3-phosphate
dehydrogenase (GPD2; Ferrer et al. 1996), which is lo-
cated in the chromosomal band 2q24.1. Mitochondrial
glycerol-3-phosphate dehydrogenase plays a major role
in glucose-stimulated insulin secretion (Ferrer et al.
1996). Another gene closely linked to D2S141 marker
is the inwardly rectifying potassium channel GIRK1
(Kir3.1, KCNJ3) [2q24.1], which is implicated in the
regulatory pathways of insulin secretion (Vionnet et al.
1997). These genes have been considered not to be com-
mon causes of type 2 diabetes in some populations
(MacDonald et al. 1997; Vionnet et al. 1997). However,
recently, some evidence has been reported in a French
population (Vionnet et al. 2000) for linkage of a dia-
betes-related phenotype to the D2S2330 marker region,
which is close and telomeric to the marker D2S141 that
showed suggestive linkage to FSI in our study.
As noted earlier, there are several other chromosomal
regions across the genome that exhibited some evidence
for linkage (i.e., LOD scores 11.5) to FSI (fig. 1). The
location (between markers D11S1984 and D11S988)
linked to FSI is ∼10 cM telomeric to the b-hemoglobin
(HBB) locus on our map, which we previously reported
to be linked with both fasting and 2-h glucose concen-
trations (Stern et al. 1996). Vionnet et al. (1997) re-
ported suggestive evidence for linkage of a severe form
of diabetes to a genetic location which overlaps with
this region on chromosome 11p (see also Vionnet et al.
2000). In fact, as we reported elsewhere (Duggirala et
al. 1999b), some evidence for linkage of both diabetes
and age of diabetes onset was found at a location be-
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tween markers D11S988 and HBB. Our second region
of interest on chromosome 11 is near the marker
D11S934, which is located between the markers
D11S4464 and D11S912. This region strongly overlaps
the genetic location (between markers D11S4464 and
D11S912) reported to be significantly linked with BMI
in Pima Indians (Hanson et al. 1998a). In fact, this
genetic location showed some evidence for linkage to
diabetes, but it provided strong evidence for bivariate
linkage of BMI and diabetes in the Pima population.
Also, this region was reported to be linked to diabetes
in a white population (Elbein et al. 1999).
Recently, the region near marker D18S535, where we
found some evidence for linkage of FSI, has been shown
to be significantly linked to fat-free body mass in the
Quebec Family Study (Chagnon et al. 2000). Also, this
region has been reported to provide some evidence for
linkage to diabetes or its related phenotypes (Ehm et al.
2000; Vionnet et al. 2000). The region linked to FSI on
chromosome 20q is near the marker D20S119. A num-
ber of linkage studies have implicated this region as
influencing type 2 diabetes (Zouali et al. 1997; Ghosh
et al. 1999, 2000; Klupa et al. 2000; Vionnet et al. 2000)
or its related traits, such as insulin secretion (Ghosh et
al. 1999), obesity (Borecki et al. 1994; Lee et al. 1999),
and energy metabolism (Norman et al. 1998). Aside
from the regions discussed thus far, Pratley et al. (1998)
found modest evidence for linkage of fasting plasma
insulin concentration and insulin action at physiologic
insulin concentrations to the D3S1764-marker region
on chromosome 3 in the Pima population. We failed to
find evidence for linkage of FSI to this region but found
that FSI was linked (LOD 1.2) to the marker D3S2460
region, which is ∼25 cM centromeric to D3S1764. Re-
cently, in another study of Mexican American families,
Mitchell et al. (2000) reported a region on chromosome
3 near markers D3S1600-D3S1285 to be strongly
linked to fasting insulin concentration. We failed to find
any evidence for linkage of FSI to this region. However,
the observed LOD curve in the study by Mitchell et al.
was broad, and it covered the region around marker
D3S2460 (LOD 11.0), where we found some evidence
for linkage of FSI.
Our study, in addition to the identification of a major
locus near marker D6S403 with significant influence on
measures of insulin and HOMA %S, provides strong
evidence for pleiotropic effects of the same location on
several IRS-related phenotypes. Also, there appears to
be another susceptibility locus near marker D6S264,
which exerts appreciable influences on various trait
pairs related to the IRS. Of the phenotypes examined
in this study, the trait pairs leptin-specific insulin and
leptin-HOMA %S appear to portray the shared major-
gene influences most effectively. Although the relation-
ship between leptin levels and diabetes is uncertain
(Haffner et al. 1996; Van Gaal et al. 1999), several
studies have reported associations between fasting in-
sulin and leptin levels (e.g., Zimmet et al. 1996; Ruige
et al. 1999). In fact, a strong phenotypic correlation
between FSI and fasting leptin concentrations (rp
, ) has been observed in a population-based0.55 P ! .001
study involving nondiabetic Mexican Americans (Haff-
ner et al. 1998). There has been considerable recent
interest in the role of insulin in leptin regulation and in
the influence of leptin on both insulin resistance and
insulin secretion (Kolaczynski et al. 1996; Lo¨nnqvist et
al. 1999; Ruige et al. 1999; Keiffer and Habener 2000).
It has been shown that insulin resistance, as measured
directly by euglycemic-hyperinsulinemic clamp, is sig-
nificantly correlated to leptin in a sample of nondiabetic
men and women (Donahue et al. 1999). According to
these authors, the rate of insulin-mediated glucose dis-
posal is significantly inversely associated with leptin
concentrations in both men ( ; ) andrp .83 P ! .001
women ( ; ).rp 0.59 P ! .001
Although some genes across the genome may be iden-
tified as having common influences on correlated phe-
notypes, such traits can also be influenced by trait-spe-
cific loci (Mahaney et al. 1995; Duggirala et al. 2000).
Aside from the findings of loci affecting specific traits,
several studies have identified genetic regions that in-
fluence correlated phenotypes (e.g., Duggirala et al.
1996; Lembertas et al. 1997; Hanson et al. 1998a;
Ghosh et al. 1999; Kissebah et al. 2000). In both theory
and practice, the genetic causes of correlation between
phenotypes through the pleiotropic effects of genes are
of particular interest (Falconer 1989). As stated by Fal-
coner (1989, p. 313), “the genetic cause of correlation
is chiefly pleiotropy,” which is “simply the property of
a gene whereby it affects two or more characters, so
that if the gene is segregating it causes simultaneous
variation in the characters it affects.” In this study, we
first found significant evidence for linkage of both in-
sulin and an indirect measure of insulin resistance to a
location near marker D6S403 on chromosome 6q that
was subsequently identified to have strong pleiotropic
influences on various IRS-related phenotypes. As part
of our ongoing efforts to identify other genetic regions
that have common influences on IRS-related traits, for
example, we have mapped several IRS-related pheno-
types (e.g., lipids and obesity measures) to a genetic
region on chromosome 7q (Duggirala et al. 1999a).
The pedigree-based variance-component approach
(the approach used in the present study) has been shown
to be a powerful technique for linkage analysis (Almasy
and Blangero 1998; Pratt et al. 2000). However, since
this technique is based on the assumption of multivar-
iate normal distribution, there has been continued in-
terest in its sensitivity to violations of this assumption
(Allison et al. 1999; Blangero et al. 2000). In general,
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this approach has been shown to be robust to such
violations (Beaty et al. 1985; Amos 1994), although
some types of nonnormality (e.g., leptokurtosis) could
result in inflated type I–error rates (Allison et al. 1999;
Blangero et al. 2000, 2001). Data simulations have
shown that trait distributions with coefficient of kur-
tosis !2 appear not to yield grossly inflated type I error
(Blangero et al. 2001). For the phenotypes used in this
study, the coefficient of kurtosis ranged from 0.9 (ln
HOMA %S) to 1.6 (LEPT). Nonetheless, as an added
precaution, in addition to the reported empirical P val-
ues to support our findings, we used a robust statistical
approach to verify our original univariate linkage find-
ings (Blangero et al. 2000, 2001). For a given pheno-
type, we obtained the empirical distribution for the
LOD scores by simulation as described earlier. A cor-
rection constant was obtained by regression of the ex-
pected LOD scores on the observed simulated LOD
scores to adjust the trait-specific observed LOD scores.
All of the phenotypes examined in this study appeared
not to require an adjustment to the observed LOD score,
with the exception of FSI, which needed a slight ad-
justment (yielding a robust corrected LOD of 3.6 versus
the observed LOD of 4.1), thus indicating that the find-
ings relating to FSI may have been slightly inflated.
Given that deviations from multivariate normality are
expected for phenotypes that are under the effects of
major genes or oligogenes, it is reassuring to note that
the findings from our analyses are consistent, despite
subtle differences in the distributional properties of the
various phenotypes used.
In conclusion, we found strong evidence for a major
locus influencing insulin concentrations and insulin re-
sistance in nondiabetic Mexican Americans, which has
significant shared effects (i.e., pleiotropy) on various
obesity-/IRS-related phenotypes as well. A positional
candidate gene for insulin resistance in this region on
chromosome 6q is the plasma cell membrane glycopro-
tein PC-1 gene. There appears to be a second suscep-
tibility locus for insulin on chromosome 6q that also
had significant pleiotropic effects on various obesity-/
IRS-related phenotypes. Given the focus on the insulin-
leptin relationship, our findings suggest that the loci on
chromosome 6q have strong shared major-gene effects
on variation in both insulin and obesity measures,
especially leptin concentrations. Presently, we are in the
process of characterizing the plasma cell membrane gly-
coprotein PC-1 gene in an effort to identify a functional
variant.
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